In this podcast, Lisa Jones, MA, RDN, LDN, speaks with Amy Bragagnini RD, CSO, a clinical oncology dietitian at Trinity Health Lacks Cancer Center in Grand Rapids, MI, to discuss foods that have gained...
Jaspal Singh, MD, MHA, MHS, moderates a roundtable discussion with Bradley L. Icard, DO, Brian Shaller, MD, and Dominique Pepper, MD, MBChB, MHSc on the impact of advanced imaging combined with robotic...
In this Q&A, Brittany A. Davidson, MD, discusses navigating goals-of-care conversations in gynecologic oncology, including how to identify patients at high risk of death who might benefit from a timely...
In this video, Jaspal Singh, MD, MHA, MHS, moderates a roundtable discussion with key experts including Bradley L. Icard, DO, Brian Shaller, MD, and Dominique Pepper, MD, ChB, MHSc on important issues...
In this interview, Elmar Joura, MD, answers questions about the long-term follow-up data on sustained immunogenicity and safety for the 9-valent human papillomavirus (HPV) vaccine, including indications,...
06/23/2024
Critical Observations in Pulmonary Medicine, Ep. 10
Critical Observations in Pulmonary Medicine, Ep. 10
In this episode, Dr Rizzo interviews Leah Backhus, MD, MPH, about the role of the thoracic surgeon in lung cancer care, including how the screening environment and the advances in surgical techniques,...
Stephanie Blank, MD, answers questions about the session she hosted at The Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer titled “The Future is Now: Determining the Fate of...
In this video, Diana Abbott, PhD, and Grace Bosma, MS, discuss their team’s study on the outcomes and intensity of first-line therapy for the treatment of diffuse large B-cell lymphoma (DLBCL) in elderly...
In this expert Q&A, Mats Enlund, MD, PhD, discusses his team's study that adds to the growing literature on the impact of general anesthesia choice on overall survival among patients undergoing breast...
In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
